JP2017061576A5 - - Google Patents

Download PDF

Info

Publication number
JP2017061576A5
JP2017061576A5 JP2017004042A JP2017004042A JP2017061576A5 JP 2017061576 A5 JP2017061576 A5 JP 2017061576A5 JP 2017004042 A JP2017004042 A JP 2017004042A JP 2017004042 A JP2017004042 A JP 2017004042A JP 2017061576 A5 JP2017061576 A5 JP 2017061576A5
Authority
JP
Japan
Prior art keywords
extract
composition containing
crude drug
solid composition
carmellose calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017004042A
Other languages
English (en)
Japanese (ja)
Other versions
JP6662312B2 (ja
JP2017061576A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017061576A publication Critical patent/JP2017061576A/ja
Publication of JP2017061576A5 publication Critical patent/JP2017061576A5/ja
Application granted granted Critical
Publication of JP6662312B2 publication Critical patent/JP6662312B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017004042A 2014-12-05 2017-01-13 固形組成物 Active JP6662312B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014246787 2014-12-05
JP2014246787 2014-12-05

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015231564A Division JP6327237B2 (ja) 2014-12-05 2015-11-27 固形組成物

Publications (3)

Publication Number Publication Date
JP2017061576A JP2017061576A (ja) 2017-03-30
JP2017061576A5 true JP2017061576A5 (enExample) 2019-01-10
JP6662312B2 JP6662312B2 (ja) 2020-03-11

Family

ID=56121796

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015231564A Expired - Fee Related JP6327237B2 (ja) 2014-12-05 2015-11-27 固形組成物
JP2017004042A Active JP6662312B2 (ja) 2014-12-05 2017-01-13 固形組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2015231564A Expired - Fee Related JP6327237B2 (ja) 2014-12-05 2015-11-27 固形組成物

Country Status (1)

Country Link
JP (2) JP6327237B2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6668706B2 (ja) * 2014-12-12 2020-03-18 大正製薬株式会社 固形組成物
JP6286383B2 (ja) * 2015-03-27 2018-02-28 小林製薬株式会社 固形医薬組成物
JP2017075136A (ja) * 2015-06-08 2017-04-20 ロート製薬株式会社 内服組成物
JP6294943B2 (ja) * 2016-10-28 2018-03-14 小林製薬株式会社 固形医薬組成物
JP7235193B2 (ja) * 2017-04-26 2023-03-08 大正製薬株式会社 固形組成物
JP6982290B2 (ja) * 2017-06-15 2021-12-17 大峰堂薬品工業株式会社 オンジエキス含有内服用固形医薬製剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04243832A (ja) * 1991-01-22 1992-08-31 Kanebo Ltd 自己免疫疾患治療剤
JPH05139982A (ja) * 1991-11-26 1993-06-08 Kanebo Ltd 虚血性脳疾患改善剤
JP4293572B2 (ja) * 1998-06-30 2009-07-08 株式会社龍角散 ロキソプロフェン・ナトリウム含有錠剤
JP5021210B2 (ja) * 2006-01-16 2012-09-05 エスエス製薬株式会社 圧縮成型製剤
JP5989960B2 (ja) * 2010-02-26 2016-09-07 小林製薬株式会社 サラシア含有組成物
JP5226732B2 (ja) * 2010-05-20 2013-07-03 エスエス製薬株式会社 催眠用圧縮成型製剤
JP5759113B2 (ja) * 2010-06-16 2015-08-05 旭化成ケミカルズ株式会社 エキス末配合錠剤
JP6062168B2 (ja) * 2011-07-01 2017-01-18 武田薬品工業株式会社 生薬由来成分を含有する製剤及びその製造方法
JP2013053144A (ja) * 2011-08-09 2013-03-21 Daiichi Sankyo Healthcare Co Ltd 鎮静剤組成物
KR20140017976A (ko) * 2012-08-03 2014-02-12 삼성제약공업주식회사 수험생용 비타 하이브리드 정제 및 그 제조 방법
JP2014166994A (ja) * 2013-02-04 2014-09-11 Rohto Pharmaceut Co Ltd 新規な漢方エキス製剤

Similar Documents

Publication Publication Date Title
DK3328843T3 (da) 1,3,4-oxadiazolsulfonamidderivat-forbindelser som histon- deacetylase-6-inhibitor, og den farmaceutske sammensætning
IL250196A0 (en) Solid dosage form composition for buccal or sublingual administration of cannabinoids
BR112017004612A2 (pt) compostos, composição farmacêutica, usos de um composto, e kit
IL250890A0 (en) Compounds for the inhibition of indoleamine-2-3-dioxygenase and pharmaceutical preparations containing them
DK3362445T3 (da) Oxadiazolaminderivatforbindelser som histondeacetylase 6-inhibitor, og den farmaceutiske sammensætning dermed
JP2017061576A5 (enExample)
HK1255102A1 (zh) 杂环化合物及其应用
DK3312177T3 (da) Tricyklisk derivatforbindelse, fremgangsmåde til at fremstille samme og farmaceutisk sammensætning omfattende samme
DK3330259T3 (da) 1,3,4-oxadiazolamidderivativ-forbindelse som histondeacetylase-6-inhibitor og farmaceutisk sammensætning indeholdende denne
NZ729037A (en) Carboxylic acid compound, method for preparation thereof, and use thereof
JP2016535100A5 (enExample)
EP3231436A4 (en) Pharmaceutical composition for prevention or treatment of metabolic disease, comprising bacteroides acidifaciens as effective ingredient
WO2016092561A3 (en) Novel polymorphs of ivacaftor, process for its preparation and pharmaceutical composition thereof
MX376202B (es) Compuestos de tiofeno condensado utiles como inhibidores de napi-iib.
EP3156055A4 (en) Pharmaceutical composition for preventing or treating muscular weakness-related diseases, containing butylpyridinium or derivative thereof
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
MX2020009444A (es) Composicion farmaceutica oral de isotretinoina con dosis baja y su proceso de preparacion.
CN106687453A8 (zh) 作为溴结构域抑制剂的四氢喹啉衍生物
EA201691924A1 (ru) Фармацевтические композиции
WO2015001541A3 (en) Pharmaceutical film composition
EP3564224A3 (en) Crystalline form of vortioxetine hydrobromide as antidepressant drug
WO2015052568A3 (en) Solid forms of curcumin and derivatives thereof
EA201792234A1 (ru) Новые соединения пиридиния
EP3244930A4 (en) PHARMACEUTICAL COMPOSITIONS WITH POH DERIVATIVES
WO2016006974A3 (en) Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof